•   Gideon Ericko Setiawan

  •   Erman Sumirat


As one of the world’s most populous countries with a fast-growing economy, Indonesia's market for pharmaceuticals has become very promising. COVID-19 pandemic that outbroken since early 2020 has brought a huge impact on the overall country condition while at the same time stimulate the growth of the pharmaceutical market as it is forecasted to grow at a CAGR of 6.3% between 2016 and 2021 according to IQVIA. This situation creates a reaction in the stock market especially of pharmaceutical companies that experienced an average increase of 67% since last year with its key driver of news regarding the distribution of Sinovac vaccine by some state-owned pharma companies as part of the national vaccination program. PT. Kalbe Farma, Tbk as one of the largest pharma companies in Indonesia is also accounting a positive growth over the years while also presented with bright prospects as a result of its strategic initiatives to collaborate with South Korea in developing COVID-19 vaccine and medication, named Genexine which is planned to be completed in Q3 2021. The possibility of success in this project might affect the company’s stock performance since it would result in bigger profitability for the company. In order to help investors to make a decision in this situation, the intrinsic value of the company stock is required. Therefore, conducting absolute and relative valuation are believed to be important in order to find the intrinsic value. This study examined absolute valuation using FCFF model and relative valuation using P/E and EV/EBITDA for KLBF. Result of the valuation suggested that the current stock price of IDR 1,445 is overvalued. The intrinsic value calculated from FCFF model is IDR 1,397 and based on the relative valuation models are IDR 1,330 and IDR 1,233 for EV/EBITDA and P/E ratio, respectively.

Keywords: COVID-19, Kalbe Farma, pharmaceutical, stock valuation


M. Saragih, and T. Nurhaida, “The impact of the COVID-19 Pandemic on Stock Investment in the Indonesian Capital Market,” Management Research and Behavior Journal, vol. 1, June 2021.

M. Alanyali, “Quantifying the Relationship Between Financial News and Stock Market,” Scientific Reports Nature Research, December 2013.

M. Welley, and N.S. Franky, “The Comparison of State-Owned Pharmaceutical Stock Price Before and After COVID-19 Vaccine Development,” JMBI UNSRAT, vol. 7, December 2020.

Kalbe Farma. (2020, May 27). Kalbe Collaborates with Genexine of South Korea to Develop COVID-19 Vaccines [Press Release]. https://www.kalbe.co.id/news-and-events/ArtMID/443/ArticleID/825/Kalbe-Collaborates-with-Genexine-of-South-Korea-to-Develop-COVID-19-Vaccines.

D. Kahneman, and A. Tversky, “Prospect Theory: An Analysis of Decision Under Risk.” Econometrica, vol. 47, March 1979.

M. Porter, “How Competitive Forces Shape Strategy.” Harvard Business Review, Vol. 57 No. 2, March 1979.

P. Barnes, “The Analysis and Use of Financial Ratios: A Review Article.” Journal of Business Finance & Accounting, vol. 14, no. 4, December 1987.

N. Singh, “SWOT Analysis – A Useful Tool for Community Vision.” Concept Paper of Central Himalayan Village, Res 2 No. 9. 2010.

Brigham, F. Eugene, and F. Houston, “Fundamentals of Financial Management 12th edition.” Mason: South-Western Cengage Learning. 2009.

A. Thompson, A.J. Stickland, and J.E. Gamble, “Crafting and Executing Strategy-Concepts and Cases,

S. Bhattacharyya, “Intrinsic Value of Share: A Conceptual Discussion.” Journal of BS University of Calcutta, vol. 33-34, 2013.

V. Ford. (2011, November 4). What is Intrinsic Value? Definition of Intrinsic Value. The Law Dictionary. https://thelawdictionary.org/intrinsic-value/#:~:text=he%20intrinsic%20value%20of%20a,everywhere%20and%20to%20every%20one.

J. Hampton, “Handbook for Financial Decision Makers.” Reston Publishing Company, pp. 543-544. 1979.

Annual Report. (2016-2020). PT Kalbe Farma Tbk.

A. Damodaran. Country Default Spreads and Risks Premiums. 2021. [Online]. Available: http://pages.stern.nyu.edu/~adamodar/New_Home_Page/datafile/ctryprem.html.

A. Damodaran. Growth Rate and Terminal Value. [Online]. 2006, Available: http://people.stern.nyu.edu/adamodar/pdfiles/ovhds/dam2ed/growthandtermvalue.pdf.

A. Damodaran. It is all relative. Multiples, Comparable and Value. 2010. [Online]. Available:


K. Brown, Reilly, and K. Frank. “Analysis of Investments and Management of Portfolios, 9th edition. South Western Cengage Learning. 2009.

K. Zelazowski, “Application of Multiple-Based Methods in Valuation of Real Estate.” Real Estate Management and Valuation, vol. 23, no. 3, 2015.

A. Pandey, and S. Sehgal, “Equity Valuation Using Price Multiples: Evidence from India.” Asian Academy of Management Journal of Accounting and Finance, vol. 6, no. 1, 2010.

D. Inezwari, “Relative Valuation Model Analysis of IDX LQ45 Stocks.” Journal of Applied Finance and Accounting, vol. 6, no. 1, 2013.

E. Persson, A. Stahlberg, “P/E and EV/EBITDA Investment Strategies vs. the Market: A Study of Market Efficiency,” Master Thesis, International Business Program., Linkoping University, Sweden, 2006.


Download data is not yet available.


How to Cite
Setiawan, G. E., & Sumirat, E. (2021). Stock Valuation of Indonesia Pharmaceutical Company with COVID-19 Vaccination Development Prospects Amidst Pandemic Situation (Case Study of PT. Kalbe Farma, Tbk.). European Journal of Business and Management Research, 6(5), 127-131. https://doi.org/10.24018/ejbmr.2021.6.5.1065